Skip to main content
RA Flare Risk Rises Following DMARD Taper to Discontinuation With Conventional Synthetics or TNF Inhibitors
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
RA Flare Risk Rises Following DMARD Taper to Discontinuation With Conventional Synthetics or TNF Inhibitors
User login
Username
Password
Reset your password
Concept
Lead
score
Rheumatoid Arthritis
1
1
Remission
0
0.86
Disease-Modifying Antirheumatic Drugs
0
0.99
Addiction
0
0.28
Nebraska
0
0.23
Arthritis
0
0.16
Drug Withdrawal
0
0.16
Hospital
0
0.16
Biologic Therapy
0
0.14
Europe
0
0.08
Glucocorticoid
0
0.08
Grant
0
0.08
Tumor
0
0.08
Specialty
Lead
score
Rheumatology
1
1
Pharmacist
0
0.7
Family Medicine/Primary Care
0
0.8
Internal Medicine
0
0.9
Edit Tags